Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic testing for the clinician in prostate cancer.

Expert review of molecular diagnostics - 1 Sept 2020

López-Campos Fernando, Linares-Espinós Estefanía, Maldonado Pijoan Xavier, Sancho Pardo Gemma, Morgan Todd Mathew, Martínez-Ballesteros Claudio, Martínez-Salamanca Juan, Couñago Felipe

Abstract excerpt

INTRODUCTION: Prostate cancer (PCa) is one of the most common cancers worldwide and a leading cause of cancer-related mortality. Although the diagnosis and treatment of prostate cancer has improved substantially in recent years, new molecular biomarkers are needed to further prolong survival and improve the quality of life in these patients. AREAS COVERED: This review analyzes the current evidence for prognostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Clinical Decision-Making

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease Management

Share to Genetic Association Studies

Share to Genetic Testing

Share to Precision Medicine

Share to Prognosis

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 32885704
DOI: 10.1080/14737159.2020.1816170

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic testing for the clinician in prostate cancer.PMID 32885704Read ↗

Genetics and Screening in Prostate Cancer.Semantic proximity Read ↗

Genetic alterations in prostate cancer as diagnostic and prognostic markers.Semantic proximity Read ↗

Prostate cancer – a biomarker perspectiveSemantic proximity Read ↗

Genomic biomarkers in prostate cancerSemantic proximity Read ↗

Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy.Semantic proximity Read ↗

Germline Genetics of Prostate Cancer: Prevalence of Risk Variants and Clinical Implications for Disease ManagementSemantic proximity Read ↗

The Genomic and Molecular Pathology of Prostate Cancer: Clinical Implications for Diagnosis, Prognosis, and TherapySemantic proximity Read ↗

Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTCSemantic proximity Read ↗

Genetic testing in prostate cancer management: Considerations informing primary care.Semantic proximity Read ↗

Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer.Semantic proximity Read ↗

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing GuidelinesSemantic proximity Read ↗

Molecular Alterations in Prostate Cancer as Diagnostic, Prognostic, and Therapeutic TargetsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.